Inhibition of LONP1 in prostate cancer: bibliometrics-guided target screening and AI-driven antibody design
The designed LONP1 inhibitory antibody offers a novel strategy for prostate cancer treatment. The proposed workflow - "bibliometric guidance - research intelligent agent screening - bioinformatics support" - proves beneficial for enhancing AI-driven scientific research and optimizing the screening of therapeutic targets for diseases.
Authors
- Jie Zhu (ORCID: https://orcid.org/0000-0002-1879-983X)
- Li Jiang (ORCID: https://orcid.org/0000-0002-2407-3672)
- Min Fan
- Yuan Zhang
- Anqi Yang
- Jiawei Pan
- Jian Shi
- Yangyang Sun
- Zhen Chen
- Yuwei Shen
Institutions
- Soochow University (CN)
- Online Technologies (United States) (US)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2026-01-19
- DOI
- https://doi.org/10.1097/js9.0000000000004705
- Primary Topic
- Mitochondrial Function and Pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00